These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6896789)

  • 1. Relapses after thionamide therapy for Graves' disease.
    Holm LE; Alinder I
    Acta Med Scand; 1982; 211(6):489-92. PubMed ID: 6896789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
    Tun NN; Beckett G; Zammitt NN; Strachan MW; Seckl JR; Gibb FW
    Thyroid; 2016 Aug; 26(8):1004-9. PubMed ID: 27266892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
    Ford HC; Feek CM; Delahunt JW
    N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
    van Soestbergen MJ; van der Vijver JC; Graafland AD
    J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.
    Cho YY; Shon HS; Yoon HD
    Korean J Intern Med; 2005 Dec; 20(4):335-8. PubMed ID: 16491833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J; Gabalec F; Svilias I; Horáček J
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatality complicating agranulocytosis in the setting of carbimazole therapy.
    Lynch MJ; Woodford NW
    Forensic Sci Med Pathol; 2008; 4(4):246-9. PubMed ID: 19291446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
    Finucane FM; O'Connell J; Kinsley BT
    Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
    Modebe O
    East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbimazole therapy in Basedow's disease: therapy results in individual dosage adjustment].
    Trabucco P; Engler H; Ryff-de Lèche A; Althaus B; Staub JJ
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1894-8. PubMed ID: 2609144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of relapse in hyperthyroid Graves' disease.
    McGregor AM; Smith BR; Hall R; Petersen MM; Miller M; Dewar PJ
    Lancet; 1980 May; 1(8178):1101-3. PubMed ID: 6103438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and endocrine features and long-term outcome of Graves' disease in early childhood.
    Bossowski AT; Reddy V; Perry LA; Johnston LB; Banerjee K; Blair JC; Savage MO
    J Endocrinol Invest; 2007 May; 30(5):388-92. PubMed ID: 17598970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
    Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M
    BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose.
    Edmonds CJ; Tellez M
    Eur J Endocrinol; 1994 Aug; 131(2):120-4. PubMed ID: 8075780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Neutropenia and Hepatotoxicity After Carbimazole Drug Therapy for Hyperthyroidism in a Pediatric Patient: A Case Report.
    Alnajjar LI; Alkahtani R; Alasqah MA; Alanizi A; Bin Sheraim N; Alwahhabi B; AlAboud M; Alhubaishi AA
    Am J Case Rep; 2023 May; 24():e939331. PubMed ID: 37226438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
    Pearce SH
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):589-94. PubMed ID: 15521961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.